ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Nomination period for the Broermann Medical Innovation Award started

By: PR Leap
(PRLeap.com)
  • Prize money of one million euros higher than the prize money for the Nobel Prize for Medicine

  • Award honors researchers worldwide who have done pioneering work in medicine, biotechnology, or related fields


  • The nomination period for the Broermann Medical Innovation Award has started. The prize, which will be awarded for the first time this year, is aimed at scientists worldwide who have carried out pioneering work in medicine, biotechnology, or related fields with their research.

    The nomination portal (www.broermann-award.org/nomination/) is open until March 1, 2025. At one million euros, the prize is more valuable than the Nobel Prize for Medicine, making it one of the most highly endowed awards for medical research worldwide.

    The international Broermann Medical Innovation Award recognizes research results that demonstrate a high level of innovation for clinical application and thus have the potential to improve the lives and health of millions of people worldwide. The prize is aimed at scientists whose research has been pioneering in the fields of medicine, biotechnology, or related sciences.

    The Broermann Medical Innovation Award was established in 2024 to honor the vision and commitment of Dr. Bernard große Broermann, the founder of the Asklepios Kliniken. The Broermann gemeinnützige GmbH sponsors the award, and the University Hospital Giessen and Marburg (UKGM) manages the organization. "With this award, we want to honor groundbreaking medical discoveries and highlight those whose research brings real improvements in the prevention or treatment of diseases," says Prof. Werner Seeger, Chairman of the Award Committee. For the Medical Director of the UKGM, Prof. Friedrich Grimminger, the unique prize reflects the clear conviction of the company founder: "Scientific excellence in medicine is always an international team effort, but without the genius of individual researchers, networks are limited in their impact. These key players and drivers of medical innovation should be promoted and recognized worldwide."

    Nomination process and deadlines
    Nominations for the Broermann Medical Innovation Award can be submitted until March 1, 2025. The incumbent Hessian Minister President will present the award in December 2025 at the Hessian State Chancellery in Wiesbaden.

    Further information on the award, the nomination criteria, and the selection process can be found at www.broermann-award.org.

    For further information, please contact:

    Broermann Medical Innovation Award
    Mirjam Malko
    Tel.: +49 (0) 641 / 985-42310
    E-Mail: contact@broermann-award.org

    Asklepios Kliniken
    Corporate Communications and Marketing
    Tel.: + 49 (0) 40 / 18 18-82 66 36
    E-Mail: presse@asklepios.com
    24-hour on-call service for the press office: +49 (0) 40 / 1818-82 8888

    Visit Asklepios on the Internet, Facebook or YouTube:
    www.asklepios.com
    www.asklepios.com/konzern/gesundheitsmagazin
    www.facebook.com/asklepioskliniken
    www.youtube.com/asklepioskliniken

    RHÖN-KLINIKUM AG
    Corporate Communications and Marketing
    Heike Ochmann
    Press Spokeswoman
    Tel.: +49 (0) 9771 / 65-12130
    E-Mail: heike.ochmann@rhoen-klinikum-ag.com

    MEDICLIN AG
    Dr. Janina Lossen 
    Press Spokeswoman
    Tel:. +49 (0) 781 / 488-180
    E-Mail: presse@mediclin.de

    UKGM
    Frank Steibli 
    Head of Communications and Press Spokesman
    Tel.: +49 (0) 641 / 985-51020
    Mobile: +49 (0) 160 / 7120456
    E-Mail: frank.steibli@uk-gm.de

    GET IN TOUCH
    Mirjam Malko
    Broermann Medical Innovation Award

    https://www.broermann-award.org/

    You can see the original version and more on PRLeap here: http://www.prleap.com/pr/302437/nomination-period-for-the-broermann-medical-innovation-award-started

    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.


     

    IntelligentValue Home
    Close Window

    DISCLAIMER

    All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

    Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.